Evolent Health, Inc, through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates as a managed services firm that supports health systems and physician organizations in migration toward value-based care and population health management. Its services include providing customers with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services, and comprehensive health plan administration services.
Read More…
Industry, Sector and Symbol
Industry Management services
Sub-IndustryN/A
SectorComputer and Technology
Phone571-389-6000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$627.06 million
Profitability
Miscellaneous
Employees3,800
Next Earnings Date11/5/2019 (Estimated)
OptionableOptionable
Evolent Health (NYSE:EVH) Frequently Asked Questions
What is Evolent Health's stock symbol?
Evolent Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVH."
How were Evolent Health's earnings last quarter?
Evolent Health Inc (NYSE:EVH) released its earnings results on Tuesday, August, 6th. The technology company reported ($0.26) earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($0.29) by $0.03. The technology company had revenue of $192 million for the quarter, compared to analyst estimates of $192.51 million. Evolent Health had a negative return on equity of 6.47% and a negative net margin of 14.67%. The company's revenue was up 33.1% on a year-over-year basis. During the same quarter last year, the firm posted ($0.03) EPS. View Evolent Health's Earnings History.
When is Evolent Health's next earnings date?
What price target have analysts set for EVH?
6 Wall Street analysts have issued 12 month price objectives for Evolent Health's stock. Their forecasts range from $10.00 to $21.50. On average, they expect Evolent Health's stock price to reach $16.75 in the next twelve months. This suggests a possible upside of 140.3% from the stock's current price. View Analyst Price Targets for Evolent Health.
What is the consensus analysts' recommendation for Evolent Health?
6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Evolent Health in the last year. There are currently 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Evolent Health.
Has Evolent Health been receiving favorable news coverage?
Media headlines about EVH stock have been trending somewhat negative recently, according to InfoTrie. The research firm identifies negative and positive media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Evolent Health earned a coverage optimism score of -1.2 on InfoTrie's scale. They also gave media coverage about the technology company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Evolent Health.
Who are some of Evolent Health's key competitors?
What other stocks do shareholders of Evolent Health own?
Who are Evolent Health's key executives?
Evolent Health's management team includes the folowing people:
- Mr. Frank J. Williams, Co-Founder, CEO & Chairman (Age 52)
- Mr. Seth Blackley, Co-Founder, Pres & Director (Age 40)
- Mr. Thomas Peterson III, Co-Founder & COO (Age 49)
- Mr. Nicholas McGrane, Chief Financial Officer (Age 51)
- Ms. Lydia Stone, VP, Chief Accounting Officer & Controller (Age 43)
When did Evolent Health IPO?
(EVH) raised $150 million in an IPO on Friday, June 5th 2015. The company issued 10,000,000 shares at $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs served as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers.
Who are Evolent Health's major shareholders?
Evolent Health's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Riverbridge Partners LLC (4.06%). Company insiders that own Evolent Health stock include Cheryl Scott, Doug S Aron, Frank J Williams, Jonathan Weinberg, Kenneth A Samet, Lydia Stone, Michael D'amato, Seth Blackley, Thomas Peterson III and Unitedhealth Group Inc. View Institutional Ownership Trends for Evolent Health.
Which major investors are buying Evolent Health stock?
EVH stock was bought by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC. Company insiders that have bought Evolent Health stock in the last two years include Doug S Aron, Kenneth A Samet and Michael D'amato. View Insider Buying and Selling for Evolent Health.
How do I buy shares of Evolent Health?
Shares of EVH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Evolent Health's stock price today?
One share of EVH stock can currently be purchased for approximately $6.97.
How big of a company is Evolent Health?
Evolent Health has a market capitalization of $589.09 million and generates $627.06 million in revenue each year. The technology company earns $-52,660,000.00 in net income (profit) each year or ($0.35) on an earnings per share basis. Evolent Health employs 3,800 workers across the globe.View Additional Information About Evolent Health.
What is Evolent Health's official website?
How can I contact Evolent Health?
Evolent Health's mailing address is 800 NORTH GLEBE RD SUITE 500, ARLINGTON VA, 22203. The technology company can be reached via phone at 571-389-6000.
MarketBeat Community Rating for Evolent Health (NYSE EVH)
MarketBeat's community ratings are surveys of what our community members think about Evolent Health and other stocks. Vote "Outperform" if you believe EVH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EVH will underperform the S&P 500 over the long term. You may vote once every thirty days.
